Metformin Use during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Wink, Krista [1 ]
Belderbos, Jose [2 ]
Dieleman, Edith [3 ]
Rossi, Maddalena [2 ]
Rasch, Coen [3 ]
Damhuis, Ronald [4 ]
Houben, Ruud [1 ]
Troost, Esther [5 ,6 ]
机构：
[1] Maastro Clin, Radiat Oncol, Maastricht, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands
[3] Amsterdam Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands
[4] Netherlands Comprehens Canc Org, Dept Res, Utrecht, Netherlands
[5] Med Fac, Dept Radiat Oncol, Dresden, Germany
[6] Univ Hosp Carl Gustav Carus, Dresden, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
NSCLC; metformin; Radiotherapy; Diabetes;
D O I：
10.1016/j.jtho.2016.11.280
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA09.06
引用
收藏
页码：S278 / S279
页数：2
相关论文
共 50 条
  • [21] CONCURRENT CHEMORADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER: COMPARISON OF TWO TREATMENT REGIMENS
    Leclerc, M.
    Raby, B.
    Leberge, F.
    Fournier, B.
    Martin, S.
    Lacasse, Y.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S60 - S61
  • [22] Consolidation Chemotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer After Concurrent Chemoradiotherapy
    Basal, F.
    Aslan, F.
    Zengin, G.
    Demirci, U.
    Oksuzoglu, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S853 - S853
  • [23] CONCURRENT CHEMORADIOTHERAPY WITH TOMOTHERAPY IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): PHASE I, DOSE-ESCALATION STUDY
    Bearz, Alessandra
    Minatel, Emilio
    Abu Rumeileh, Imad
    Gobitti, Carlo
    Baresic, Tanja
    Drigo, Annalisa
    Talamini, Renato
    Vaccher, Emanuela
    Santarossa, Sandra
    Franchin, Gianni
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1553 - S1553
  • [24] Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy (CRT) in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
    Tanaka, K.
    Okamoto, I.
    Yamamoto, N.
    Hattori, Y.
    Masuda, N.
    Nishio, M.
    Takeda, K.
    Seto, T.
    Nishimura, Y.
    Nakagawa, K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S605 - S605
  • [25] Induction chemotherapy followed by concurrent chemoradiotherapy (CRT) and surgery in locally advanced non-small cell lung carcinoma (NSCLC)
    Costa, MA
    Zukin, M
    Pinel, MI
    Roriz, W
    Zamboni, MM
    Cunha, ET
    Cordeiro, PB
    Torquato, E
    Goncalves, MCC
    Campos, L
    ANNALS OF ONCOLOGY, 1998, 9 : 94 - 95
  • [26] Cetuximab in combination with concurrent chemoradiotherapy (CRT) in locally advanced non-small cell lung carcinoma (NSCLC): A feasibility study
    van den Heuvel, M. M.
    Belderbos, J.
    Dalesio, O.
    van der Pol, M.
    Uitterhoeve, L.
    van de Vaart, P.
    Verheij, M.
    van Zandwijk, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Docetaxel (D, Taxotere®) with concurrent radiation in locally advanced non-small cell lung cancer (NSCLC)
    Aamdal, S
    Hagen, I
    Avril, I
    Lauvvang, G
    Owre, K
    Hatlevoll, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S260 - S260
  • [28] Neoadjuvant chemotherapy and chemoradiotherapy for locally advanced non small cell lung cancer (NSCLC)
    Gavila, Q
    Almendros, P
    Camps, C
    López-Torrecillas, J
    Safont, M
    Blasco, A
    Garde, J
    Juarez, A
    Iranzo, V
    Sirera, R
    LUNG CANCER, 2005, 49 : S379 - S380
  • [29] Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant
    MacRae, R
    Shyr, Y
    Johnson, D
    Choy, H
    RADIOTHERAPY AND ONCOLOGY, 2002, 64 (01) : 37 - 40
  • [30] Concurrent chemoradiotherapy in non-small cell lung cancer
    O'Rourke, Noelle
    Roque i Figuls, Marta
    Farre Bernado, Nuria
    Macbeth, Fergus
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (06):
12345